Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Past Earnings Performance
Past criteria checks 0/6
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi's earnings have been declining at an average annual rate of -284.4%, while the Medical Equipment industry saw earnings growing at 9.4% annually. Revenues have been declining at an average rate of 17.9% per year.
Key information
-284.4%
Earnings growth rate
-96.9%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -17.9% |
| Return on equity | -34.4% |
| Net Margin | -33.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 241 | -80 | 81 | 0 |
| 30 Sep 23 | 172 | 3 | 46 | 0 |
| 30 Jun 23 | 159 | 18 | 37 | 0 |
| 31 Mar 23 | 141 | 27 | 30 | 0 |
| 31 Dec 22 | 293 | -21 | 66 | 0 |
| 30 Sep 22 | 173 | 93 | 27 | 0 |
| 31 Dec 21 | 128 | 72 | 16 | 0 |
Quality Earnings: ONCSM is currently unprofitable.
Growing Profit Margin: ONCSM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ONCSM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ONCSM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ONCSM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).
Return on Equity
High ROE: ONCSM has a negative Return on Equity (-34.45%), as it is currently unprofitable.